'Syngene International Ipo' - 12 News Result(s)
- Business | Press Trust of India | Thursday September 17, 2015Some of the companies that are trading above their issue price include Navkar Corporation, Syngene International, PNC Infratech and VRL Logistics.
www.ndtv.com/business
- Business | NDTV | Tuesday August 11, 2015Syngene International's IPO was subscribed over 32 times last month, helping it raise an estimated Rs 550 crore. The company had also raised Rs 150 crore from anchor investors. The IPO had opened on July 27 and closed on July 29.
www.ndtv.com/business
- Business | Press Trust of India | Sunday August 2, 2015The move follows the blockbuster IPO of Syngene International, biotechnology major Biocon's research arm. With this public offer, the company is expected to be valued at around Rs 15,000 crore.
www.ndtv.com/business
- Business | Press Trust of India | Wednesday July 29, 2015In a strong show, the Rs 550-crore initial public offer (IPO) of biotechnology major Biocon's research arm, Syngene International, was over-subscribed 32.03 times on its last day on Wednesday as both retail and institutional investors bid aggressively for the shares.
www.ndtv.com/business
- Business | Press Trust of India | Tuesday July 28, 2015Syngene International's initial public offer (IPO) was over-subscribed on its second day on Tuesday.
www.ndtv.com/business
- Business | Press Trust of India | Monday July 27, 2015The IPO received bids for 51.66 lakh shares against 1.6 crore on offer, according to NSE data till 1600 hours.
www.ndtv.com/business
- Business | NDTV | Tuesday July 28, 2015Syngene International is offering 2.2 crore shares in the price band of Rs 240-Rs 250. The issue is essentially an offer for sale wherein proceeds from the IPO will not be ploughed back in the company. Its parent Biocon is selling 11 per cent stake in the company which will bring down its stake to 74.5 per cent from 85.5 per cent now.
www.ndtv.com/business
- Business | Press Trust of India | Saturday July 25, 2015Syngene's initial public offer (IPO) will open on July 27.
www.ndtv.com/business
- Business | NDTV | Friday July 24, 2015Biocon said the biopharmaceuticals segment benefitted from a strong contribution from the insulin and biosimilar business in the emerging markets.
www.ndtv.com/business
- Business | Thomson Reuters | Thursday July 16, 2015Syngene provides contract drug discovery, research and manufacturing services to 17 of the world's top 20 pharmaceutical companies, including Bristol Myers Squibb & Co and Abbott Laboratories Ltd. Its revenue rose 25 percent in the last three years.
www.ndtv.com/business
- Business | Thursday April 23, 2015The company filed for the draft red herring prospectus with Sebi. It plans to raise Rs 600 crore by selling 24 million equity shares.
www.ndtv.com/business
- Business | Thomson Reuters | Tuesday March 31, 2015Biocon last year sold a 10 percent stake in Syngene to private equity fund Silver Leaf Oak, valuing Syngene at Rs 3800 crore.
www.ndtv.com/business
'Syngene International Ipo' - 12 News Result(s)
- Business | Press Trust of India | Thursday September 17, 2015Some of the companies that are trading above their issue price include Navkar Corporation, Syngene International, PNC Infratech and VRL Logistics.
www.ndtv.com/business
- Business | NDTV | Tuesday August 11, 2015Syngene International's IPO was subscribed over 32 times last month, helping it raise an estimated Rs 550 crore. The company had also raised Rs 150 crore from anchor investors. The IPO had opened on July 27 and closed on July 29.
www.ndtv.com/business
- Business | Press Trust of India | Sunday August 2, 2015The move follows the blockbuster IPO of Syngene International, biotechnology major Biocon's research arm. With this public offer, the company is expected to be valued at around Rs 15,000 crore.
www.ndtv.com/business
- Business | Press Trust of India | Wednesday July 29, 2015In a strong show, the Rs 550-crore initial public offer (IPO) of biotechnology major Biocon's research arm, Syngene International, was over-subscribed 32.03 times on its last day on Wednesday as both retail and institutional investors bid aggressively for the shares.
www.ndtv.com/business
- Business | Press Trust of India | Tuesday July 28, 2015Syngene International's initial public offer (IPO) was over-subscribed on its second day on Tuesday.
www.ndtv.com/business
- Business | Press Trust of India | Monday July 27, 2015The IPO received bids for 51.66 lakh shares against 1.6 crore on offer, according to NSE data till 1600 hours.
www.ndtv.com/business
- Business | NDTV | Tuesday July 28, 2015Syngene International is offering 2.2 crore shares in the price band of Rs 240-Rs 250. The issue is essentially an offer for sale wherein proceeds from the IPO will not be ploughed back in the company. Its parent Biocon is selling 11 per cent stake in the company which will bring down its stake to 74.5 per cent from 85.5 per cent now.
www.ndtv.com/business
- Business | Press Trust of India | Saturday July 25, 2015Syngene's initial public offer (IPO) will open on July 27.
www.ndtv.com/business
- Business | NDTV | Friday July 24, 2015Biocon said the biopharmaceuticals segment benefitted from a strong contribution from the insulin and biosimilar business in the emerging markets.
www.ndtv.com/business
- Business | Thomson Reuters | Thursday July 16, 2015Syngene provides contract drug discovery, research and manufacturing services to 17 of the world's top 20 pharmaceutical companies, including Bristol Myers Squibb & Co and Abbott Laboratories Ltd. Its revenue rose 25 percent in the last three years.
www.ndtv.com/business
- Business | Thursday April 23, 2015The company filed for the draft red herring prospectus with Sebi. It plans to raise Rs 600 crore by selling 24 million equity shares.
www.ndtv.com/business
- Business | Thomson Reuters | Tuesday March 31, 2015Biocon last year sold a 10 percent stake in Syngene to private equity fund Silver Leaf Oak, valuing Syngene at Rs 3800 crore.
www.ndtv.com/business